Lv42
530 积分 2025-03-19 加入
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
29分钟前
待确认
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
2小时前
已完结
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
7小时前
已完结
皖公网安备34019202002308
